within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CD06_Rimegepant;
model Rimegepant 
   extends Pharmacolibrary.Drugs.ATC.N.N02CD06;

  annotation(Documentation(
    info ="<html><body><p>Rimegepant is an orally administered, small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist used for the acute and preventive treatment of migraine in adults. It is an FDA-approved medication that reduces the occurrence and severity of migraine attacks by blocking the binding of CGRP to its receptor.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after administration of a single oral dose in the fasted state.</p><h4>References</h4><ol><li><p>Bhardwaj, R, et al., &amp; Bertz, RJ (2023). Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants. <i>Headache</i> 63(5) 652–662. DOI:<a href=&quot;https://doi.org/10.1111/head.14512&quot;>10.1111/head.14512</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37140071/&quot;>https://pubmed.ncbi.nlm.nih.gov/37140071</a></p></li><li><p>Bhardwaj, R, et al., &amp; Bertz, R (2022). P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects. <i>Clinical pharmacology in drug development</i> 11(7) 889–897. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1088&quot;>10.1002/cpdd.1088</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35304977/&quot;>https://pubmed.ncbi.nlm.nih.gov/35304977</a></p></li><li><p>Bertz, R, et al., &amp; Croop, R (2023). A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants. <i>Cephalalgia : an international journal of headache</i> 43(6) 3331024231179131–None. DOI:<a href=&quot;https://doi.org/10.1177/03331024231179131&quot;>10.1177/03331024231179131</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37282507/&quot;>https://pubmed.ncbi.nlm.nih.gov/37282507</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Rimegepant;
